Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Amlodipine/Atorvastatin
DRUG
3 trials
Sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions
Angina Pectoris
Dyslipidemia
Familial Hypercholesterolemia
Hypercholesterolemia
Hypertension
Phase 3
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
Completed
NCT00330785
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Dyslipidemia, Hypertension
Start: 2004-10-31
End: 2005-09-30
Target: 1250
Updated: 2021-01-27
Phase 4
Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population
Completed
NCT00150384
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Dyslipidemia, Hypertension
Start: 2004-07-31
End: 2005-08-31
Target: 500
Updated: 2021-01-27
Unknown Phase
Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Completed
NCT01107743
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Angina Pectoris, Familial Hypercholesterolemia, Hypercholesterolemia +1
Start: 2010-06-30
End: 2012-04-30
Updated: 2021-01-28